| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2848943 | American Heart Journal | 2009 | 7 Pages |
Abstract
The results of the TRIAS Program will provide information on a relevant patient population with coronary artery lesions, comprising the full spectrum of low risk and high risk of restenosis treated with a novel stent technology in a randomized, controlled manner (TRIAS Low Risk trial: ISRCTN 47701105 and TRIAS High Risk trial: ISRCTN 74297220)
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Margo MD, Marcel A.M. MD, Niels J.W. MD, Jan G.P. PhD, Robbert J. MD, PhD, FESC, on behalf of all TRIAS Investigators on behalf of all TRIAS Investigators,